Breaking News
Sort by:
Top Post
Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease
An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]
Astellas Submits New Drug Application for Zolbetuximab in Japan
Astellas Pharma has announced the submission of a New Drug Application (NDA) on June 9, […]
Takeda and HUTCHMED Announce New Drug Application (NDA) for Fruquintinib for Treatment of Previously Treated Metastatic Colorectal Cancer Granted Priority Review
Takeda and HUTCHMED have announced that the U.S. Food and Drug Administration (“FDA”) has granted […]
Quizartinib NDA Review for Patients with Newly Diagnosed FLT3-ITD Positive AML Extended by FDA
Daiichi Sankyo has announced that the United States Food and Drug Administration (FDA) has extended […]
Aurion Biotech Receives Approval from Japan’s PMDA for New Drug Application
Aurion Biotech, whose mission is to restore vision to millions of patients with its life-changing […]
Daewoong Pharmaceutical Submitted NDA for its Global New Drug Fexuclue in 11 Countries
Fexuclue from Daewoong Pharmaceutical is attracting attention as a game changer in the global gastroesophageal […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more